Fair value · AGNC Investment Corp. (AGNCO) · updated 2026-09-03 · from 10-K FY2025
Cboe · delayed 15 min · as of 13:27 ET
Are those assumptions reasonable? Use AGNCO’s filed growth history and the AI chat to decide, then set your own inputs below — the range you build is yours.
What the price implies
price ÷ trailing EPS
per year for 10 years, discounted at 10%
(market cap + net debt) ÷ EBITDA
free cash flow ÷ enterprise value (148× EV/FCF)
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings. This price: Cboe · delayed 15 min · as of 13:27 ET.
With preset inputs the methods land at $26 – $33 (presets are filed history and our reference settings, not a recommendation)
Bear, base and bull are the 25th, 50th and 75th percentile of the methods that produced a usable estimate. Weights say how much a method is trusted for this sector; they do not change the range.
| Method | Estimate | vs price | Weight | Why this method |
|---|---|---|---|---|
Graham Number Low weight Benjamin Graham’s 1949 rule of thumb: √(22.5 × EPS × book value). It punishes asset-light companies, so it reads low for big tech. | $22 | -15% | Low weight | Benjamin Graham’s 1949 rule of thumb: √(22.5 × EPS × book value). It punishes asset-light companies, so it reads low for big tech. |
P/E vs sector Medium weight Trailing diluted EPS times the sector median P/E. What the stock would be worth if the market priced it like an average peer. | $30 | +15% | Medium weight | Trailing diluted EPS times the sector median P/E. What the stock would be worth if the market priced it like an average peer. |
Growth-trajectory DCF Medium weight A two-stage DCF that grows earnings at the company’s own EPS trend, then fades to the industry’s long-run rate. Two-stage DCF using weighted EPS CAGR and industry median terminal rate | $36 | +41% | Medium weight | A two-stage DCF that grows earnings at the company’s own EPS trend, then fades to the industry’s long-run rate. |
DCF High weight Projects free cash flow for the coming years and discounts it back to today. The most complete method, and the most sensitive to the growth and discount-rate assumptions. estimate at or below $0, or more than 4× away from the price | Not meaningful for this company | High weight | Projects free cash flow for the coming years and discounts it back to today. The most complete method, and the most sensitive to the growth and discount-rate assumptions. | |
P/B vs sector Medium weight Sector median price-to-book times book value per share. Works for banks and asset-heavy businesses, says little about software. P/B comparable is optional for non-financial companies | No estimate | Medium weight | Sector median price-to-book times book value per share. Works for banks and asset-heavy businesses, says little about software. | |
EV/EBITDA Medium weight Values the whole business at 10× EBITDA and divides by the share count. A mid-cycle industrial multiple; fast growers trade far above it. estimate at or below $0, or more than 4× away from the price | Not meaningful for this company | Medium weight | Values the whole business at 10× EBITDA and divides by the share count. A mid-cycle industrial multiple; fast growers trade far above it. | |
EV/FCF Medium weight 20× free cash flow per share, i.e. a 5% cash yield. Reads low for companies the market expects to keep growing. estimate at or below $0, or more than 4× away from the price | Not meaningful for this company | Medium weight | 20× free cash flow per share, i.e. a 5% cash yield. Reads low for companies the market expects to keep growing. | |
Earnings Power Value Low weight Greenwald’s Earnings Power Value: what current earnings are worth if they never grow. Everything above it is what you pay for growth. Not applicable for financial/REIT companies | No estimate | Low weight | Greenwald’s Earnings Power Value: what current earnings are worth if they never grow. Everything above it is what you pay for growth. | |
10-K FY2025 · fiscal year ended 2025-12-31 · filed 2026-02-23 · accession 0001423689-26-000043
Trailing-twelve-month EPS also uses the quarterly 10-Qs through Q2 FY2026 (filed 2026-07-31).
Open this filing on sec.govEvery method that could be solved backwards opens on the assumption today’s price makes, so the top range sits on the price — that is arithmetic, not a view. Change any input and it becomes yours.
We don’t tell you what AGNCO is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has AGNCO’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.
Discounted cash flow
$25.70per share
0% below the $25.70 price
Your stage-1 FCF growth (21.1%) matches the 21.1% the price implies — your value lands on today’s price.
Your inputs — two-stage free-cash-flow model
Implied by today’s price
At $25.70 the market implies a stage-1 FCF growth of 21.1%. (two-stage FCF model solved for stage-1 growth at 3.83% WACC)
Implied discount rate (holding growth): 3.8% · the WACC that makes the same model print the price
This tab opens on that number, so the value above is today’s price restated. Move the slider to what you find reasonable: the growth matrix shows what AGNCO has actually filed, and the AI chat will reason it through with you.
Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.
Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.
How long stage-1 growth lasts.
Slower growth after stage 1, before the terminal phase.
Growth forever after the two stages. Above ~3% is rarely justified.
The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.
| Year | Stage | FCF | Present value |
|---|---|---|---|
| 1 | Stage 1 | $791M | $762M |
| 2 | Stage 1 | $958M | $889M |
| 3 | Stage 1 | $1,160M | $1,036M |
| 4 | Stage 1 | $1,405M | $1,209M |
| 5 | Stage 1 | $1,702M | $1,410M |
| 6 | Stage 2 | $1,787M | $1,426M |
| 7 | Stage 2 | $1,876M | $1,442M |
| 8 | Stage 2 | $1,970M | $1,459M |
| 9 | Stage 2 | $2,069M | $1,475M |
| 10 | Stage 2 | $2,172M | $1,492M |
Inputs from the filing
10-K FY2025 · period ended 2025-12-31 · filed 2026-02-23 · accession 0001423689-26-000043 · sec.gov
Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for AGNCO
Download the full AGNCO valuation report (PDF) — free
DCF fair value, Graham number, EPV, key multiples and growth rates in one clean PDF.